Foresite Capital is an equity firm focused on healthcare. The firm officially named Molly He, Ph.D. a venture partner. Dr. Molly previously worked at Illumina as a senior director. She has gained over 15 years of experience in genomic research and pharmaceutical and holds a good record in scientific research. Foresite Capital warmly welcomed her to their team of experts. Jim Tananbaum, the CEO at Foresite Capital, stated that partnering with Dr. Molly is a remarkable step in transforming, expanding, and diversifying the company’s portfolio.
Dr. He studied at Nankai University where she majored in Biochemistry. She later joined California University for her Ph.D. in protein biophysics. For the record, she has published over 20 papers and has more than 20 patent applications. Further, she holds a patent in personalized medicine and next-generation sequencing. Dr. Molly recognized spontaneous innovation as one of the major sources of success in the company.
Dr. Molly was responsible for global protein reagent innovation and improvements at Illumina. Molly equally served at Pacific Biosciences as the head of protein sciences. In this capacity, Dr. Molly was responsible for protein reagent development. She also worked in the pharmaceutical industry for ten years and gained extensive skills in antibody structural based design and production of molecular drugs that particularly targets immune diseases and cancer.
Dr. Jim Tananbaum first established Foresite Capital in 2011. According to Crunchbase.com, he serves as the president, chief executive officer, and chair of this company. Besides, Dr. Jim has invested in 20 other healthcare firms that include Jazz Pharmaceuticals, Amerigroup, and Amira Pharmaceuticals among others. Dr. Jim has gained exceptional managerial skills while serving in top positions that include his roles as the chief executive officer at GelTex Pharmaceutical and Theravance.
In summary, Dr. Jim received and M.D from Harvard Medical School. Additionally, He received B.S and B.S.E.E from Yale University. Further, he served as an adviser to various boards at Harvard and senior staff at Yale University, school of engineering. His core aim of establishing Foresite was to provide capital to private and public healthcare startups to meet profitability. View Jim’s full bio on Bloomberg.com.